Latest filing published 02 Jul 2024 for bioAffinity Technologies, Inc..
This profile gathers the share dealings of Roby Joyce in bioAffinity Technologies, Inc. Between 1 October 2023 and 1 July 2024, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 2 July 2024 came the latest disclosure, a share grant in bioAffinity Technologies, Inc. Typically, a trade is published a median of 13 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations